BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17283066)

  • 1. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.
    Stankovic-Valentin N; Deltour S; Seeler J; Pinte S; Vergoten G; Guérardel C; Dejean A; Leprince D
    Mol Cell Biol; 2007 Apr; 27(7):2661-75. PubMed ID: 17283066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.
    Dehennaut V; Loison I; Dubuissez M; Nassour J; Abbadie C; Leprince D
    J Biol Chem; 2013 Apr; 288(15):10254-64. PubMed ID: 23417673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dissection of the interaction between HIC1 and SIRT1.
    Dehennaut V; Loison I; Pinte S; Leprince D
    Biochem Biophys Res Commun; 2012 May; 421(2):384-8. PubMed ID: 22510409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.
    Zhao X; Sternsdorf T; Bolger TA; Evans RM; Yao TP
    Mol Cell Biol; 2005 Oct; 25(19):8456-64. PubMed ID: 16166628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.
    Van Rechem C; Boulay G; Pinte S; Stankovic-Valentin N; Guérardel C; Leprince D
    Mol Cell Biol; 2010 Aug; 30(16):4045-59. PubMed ID: 20547755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.
    Deltour S; Pinte S; Guerardel C; Wasylyk B; Leprince D
    Mol Cell Biol; 2002 Jul; 22(13):4890-901. PubMed ID: 12052894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.
    Bouras T; Fu M; Sauve AA; Wang F; Quong AA; Perkins ND; Hay RT; Gu W; Pestell RG
    J Biol Chem; 2005 Mar; 280(11):10264-76. PubMed ID: 15632193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties.
    Pinte S; Stankovic-Valentin N; Deltour S; Rood BR; Guérardel C; Leprince D
    J Biol Chem; 2004 Sep; 279(37):38313-24. PubMed ID: 15231840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).
    Van Rechem C; Rood BR; Touka M; Pinte S; Jenal M; Guérardel C; Ramsey K; Monté D; Bégue A; Tschan MP; Stephan DA; Leprince D
    J Biol Chem; 2009 Jul; 284(31):20927-35. PubMed ID: 19525223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.
    Stankovic-Valentin N; Verger A; Deltour-Balerdi S; Quinlan KG; Crossley M; Leprince D
    FEBS J; 2006 Jul; 273(13):2879-90. PubMed ID: 16762039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).
    Paget S; Dubuissez M; Dehennaut V; Nassour J; Harmon BT; Spruyt N; Loison I; Abbadie C; Rood BR; Leprince D
    Oncotarget; 2017 Jan; 8(2):2916-2935. PubMed ID: 27935866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.
    Fleuriel C; Touka M; Boulay G; Guérardel C; Rood BR; Leprince D
    Int J Biochem Cell Biol; 2009 Jan; 41(1):26-33. PubMed ID: 18723112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
    Grégoire S; Yang XJ
    Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of HIC1 (Hypermethylated in Cancer 1) Ser694 by ATM is essential for DNA repair.
    Paget S; Dubuissez M; Page A; Dehennaut V; Loison I; Spruyt N; Leprince D
    Biochem Biophys Res Commun; 2021 May; 553():51-57. PubMed ID: 33756345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.
    Boulay G; Dubuissez M; Van Rechem C; Forget A; Helin K; Ayrault O; Leprince D
    J Biol Chem; 2012 Mar; 287(13):10509-10524. PubMed ID: 22315224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.
    Fu M; Wang C; Wang J; Zhang X; Sakamaki T; Yeung YG; Chang C; Hopp T; Fuqua SA; Jaffray E; Hay RT; Palvimo JJ; Jänne OA; Pestell RG
    Mol Cell Biol; 2002 May; 22(10):3373-88. PubMed ID: 11971970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
    Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
    Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
    Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
    Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.
    Wilson BJ; Tremblay AM; Deblois G; Sylvain-Drolet G; Giguère V
    Mol Endocrinol; 2010 Jul; 24(7):1349-58. PubMed ID: 20484414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.